McLean, Virginia-based Perthera Inc. received $500,000 and $1 million in matching funds to support development of its precision oncology platform. Todd Bauer, a UVA professor of surgery and project team lead at Perthera, said the company has the most advanced platform for a precision oncology approach to treating pancreatic cancer.